Meeting to be held on April 3-4 hosted by Oppenheimer.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRDL:
- Cardiol Therapeutics Advances Heart Disease Treatments with Promising Clinical Results
- CRDL Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Cardiol Therapeutics Schedules Annual General Meeting for May 2025
- Cardiol Therapeutics to Present at TD Cowen Health Care Conference
- Promising Potential of Cardiol Therapeutics’ CRD-38 Justifies Buy Rating Amidst Market Need for HFpEF Treatment